MIRA INFORM REPORT

 

 

Report Date :

08.10.2012

 

IDENTIFICATION DETAILS

 

Name :

JOHNSON AND JOHNSON LIMITED

 

 

Registered Office :

Spencer’s Building, 30, Forjett Street, August Kranti, Mumbai – 400 036, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

05.09.1957

 

 

Com. Reg. No.:

11-010928

 

 

Capital Investment / Paid-up Capital :

Rs.144.000 millions

 

 

CIN No.:

[Company Identification No.]

U33110MH1957PLC010928

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMJ05781G

 

 

Legal Form :

A Closely Held Public Limited Liability Company  

 

 

Line of Business :

Manufacturing and Selling of various Healthcare Products.

 

 

No. of Employees :

108300 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (67)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 32790000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having fine track. Financial position of the company appears to be sound. However trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Management non co-operative

 

 

LOCATIONS

 

Registered Office :

Spencer’s Building, 30, Forjett Street, August Kranti, Mumbai – 400 036, Maharashtra, India

Tel. No.:

91-22-23861431 / 24241431/23861451 / 66646464

Fax No.:

91-22-23871482 / 23801482

E-Mail :

info@jnjindia.com

sales@jnjindia.com

smoorthy@jnjin.jnj.com

Website :

http://www.jnjindia.com

 

 

DIRECTORS

 

AS ON 26.09.2011

 

Name :

Mr. Swami Kumar Gajanan Raote

Designation :

Managing Director

Address :

Samarath Ashraya, 64/P, Parel, Mumbai – 400 012, Maharashtra, India 

Date of Birth/Age :

23.05.1964

Qualification :

B. Pharm, P.G.D.M., D.C.P.

Date of Appointment :

02.04.2009

PAN No.:

AABPR2709J

DIN No.:

02610317

 

 

Name :

Mr. Vaidheesh Annaswamy

Designation :

Whole Time Director

Address :

D5, Sea Face Park, 50, Bhulabhai Desai Road, Mumbai – 400 026, Maharashtra, India

Date of Birth/Age :

16.09.1959

Date of Appointment :

12.03.2007

PAN No.:

ACGPV5317B

DIN No.:

01444303

 

 

Name :

Mr. Rajan Sunderdas Tejua

Designation :

Whole time Director

Address :

7 W and 8W, 5th and 6th Floor, Shimira, 16th Road, Khar (West), Mumbai – 400 052, Maharashtra, India

Date of Birth/Age :

17.09.1960

Date of Appointment :

14.12.2006

PAN No.:

AACPT0045N

DIN No.:

01478969

 

 

Name :

Mr. Marco Philipus Ardeshir Wadia

Designation :

Director

Address :

Thakur Nivas 173, Jamshedji Tata Road , Mumbai – 400 020, Maharashtra, India

Date of Birth/Age :

30.01.1956

Date of Appointment :

28.11.2003

DIN No.:

00244357

 

 

Name :

Mr. Suresh Narsappa Talwar

Designation :

Alternate Director

Address :

10, Shiv Shanti Bhuvan, 146, Maharshi Karve Road, Churchgate, Reclamation, Mumbai – 400 020, Maharashtra, India

Date of Birth/Age :

21.11.1938

Date of Appointment :

28.04.2011

DIN No.:

00001456

 

 

KEY EXECUTIVES

 

Name :

Mr. Anil Vasantrai Upadhyay

Designation :

Secretary

Address :

81 – A, Twin Towers, Off Veer Savarkar Marg, Prabhadevi , Mumbai – 400 025, Maharashtra, India

Date of Birth/Age :

22.09.1958

Date of Appointment :

01.09.2000

PAN No.:

AAAPU0992M

 


 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 26.09.2011

 

Names of Shareholders

No. of Shares

Johnson and Johnson, USA

1080000

Depuy Medical Private Limited, India 

360000

TOTAL

1440000

 

AS ON 26.09.2011

 

Equity Shares Break Up

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

75.00

Bodies corporate

25.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Selling of various Healthcare products.

 

 

Products :

Product Description

Item Code No. (ITC Code)

Medicaments

30.03

Sutures

30.06

Skin Care Preparations

33.04

 

 

PRODUCTION STATUS (AS ON : 31.03.2011)

 

Particulars

Unit

Licensed Capacity

Pressure sensitive adhesive tapes

Meters

1316160

Sutures & Other surgeon's requisites

Dozens

360000

Ortho Pharmaceutical Corporation

 

 

Lubricating Jelly

Tones

590

Johnson's ** baby products

Tones

2075

Shampoo

Tones

12

Johnson's ** prickly heat products

Tones

330

Toothbrushes

--

Unlimited

Orthopaedic plaster of paris bandages

Meters

329040

Sanitary protection products

Units

216 Million

Surgical Powders

Tones

180

 

** Trade Mark

 

Particulars

Unit

Installed Capacity

Actual Production

Pressure sensitive adhesive tapes :

 

 

 

Drug varieties

Meters

13.60 Lakhs

248034

Sutures and other surgeons' requisites :

 

 

 

Sterilised surgical sutures and surgeons' requisites

Dozens

142.30 Lakhs

3319585

Non-sterile sutures

Meters

181.31 Lakhs

--

Sterilising fluids

Kilolitres

8140.000

--

Gauze and bandages

Sq. Meters

13.36 Lakhs

--

Eyepads

Units

18.00 Lakhs

--

Surgipads

Sq. Meters

170.00 Lakhs

--

Orthopaedic plaster of paris bandages

Meters

63.63 Lakhs

--

Baby, prickly heat and adult powders

Tones

7884

5534

Miscellaneous baby products, gynecic and therapeutic products

Tones

14830

9125

Sanitary protection products

Millions

562

1633

Cotton Buds

Millions

1437

--

Surgical powder

Tones

45

--

Dental floss

Meters

160 Lakhs

--

Ointments

Tones

345

57

Chemicals

Tones

100

--

Tablets

Millions

4.40

313

Capsules

Millions

--

13

Liquids

Kiloliters

--

1192

Endovascular Surgical Accessories*

Pieces

--

48812

 

* The quantitative information for the noted categories has been disclosed in the current year based on the primary selling unit of measurement instead of secondary selling unit of measurement as disclosed in the previous year and hence the previous year’s number are not comparable for such categories

 

 

GENERAL INFORMATION

 

No. of Employees :

108300  (Approximately)

 

 

Bankers :

The Hong Kong and the Shanghai Banking Corporation Limited, 52/60, Mahatma Gandhi Road, Fort, Mumbai – 400 001, Maharashtra, India

 

 

Facilities :

Unsecured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

Rupee term loans unsecured

 

 

Rupee term loans banks unsecured

0.000

550.000

Rupee term loans others unsecured

0.000

166.667

 

 

 

TOTAL

0.000

716.667

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Lovelock and Lewes

Chartered Accountants

Address :

252, Veer Savarkar Marg, Shivaji Park, Dadar , Mumbai – 400 028, Maharashtra, India

PAN No.:

AABFL5878L

 

 

Holding Company :

Johnson and Johnson, U.S.A

 

 

Subsidiaries :

Deshraj Investments and Trading Company Limited

CIN No.:- U65990MH1981PLC023828

 

Key to Riches Investment and Leasing Limited

CIN No.:- U67120MH1987PTC043329

 

Loyalty Investments and Enterprises Limited

CIN No.:- U67120MH1984PTC032582

 

Suryalay Investment and Trading Company Limited

CIN No.:- U65990MH1981PLC023690

 

 

Fellow Subsidiaries / Associate Enterprises with whom the Company has transactions :

  • Advanced Sterilization Products, USA
  • Babycentre LLC
  • Benefit Risk Management, Australia
  • Biosense Webster Inc., USA
  • Centocor U.S.A.
  • Cilag AG International, Switzerland
  • Cilag Gmbh International, Germany
  • Cilag GMBH International, Switzerland
  • Codman and Shurtle Inc., USA
  • Codman Sarl, Switzerland
  • Codman U.S.A.
  • Cordis Corporation, USA
  • Cordis Europa N.V., Netherlands
  • Cordis GMBH
  • Depuy International U.K.
  • Depuy Ireland Ltd
  • Depuy Leeds
  • Depuy Mitek, U.S.A.
  • Depuy Orthopaedics USA
  • Depuy Spine Inc., U.S.A.
  • Depuy USA
  • Ethicon Endo Surgery (Europe) Gmbh, Germany
  • Ethicon Endo Surgery Inc., USA
  • Ethicon Endo Surgery Peurto Rico
  • Ethicon Inc., USA
  • Ethicon Inc., Italy
  • Ethicon LLC. U.S.A.
  • Ethicon Limited U.K.
  • Ethicon Sarl, Switzerland
  • Global Pharmaceutical Supply corporation LLC
  • GMED Healthcare, Belgium
  • Health Media, Inc
  • Information Technology Infrastructure Services
  • JandJ Medical (PTY) Limited, South Africa
  • J.C. General Services CVBA, Belgium
  • Janssen Biologics BV, Netherland
  • Janssen Cilag Limited, Thailand
  • Janssen Cilag Limited, UK
  • Janssen Cilag Pty Limited, Australia
  • Janssen Cilag, China
  • Janssen Cilag, Italy
  • Janssen Cilag, Malaysia
  • Janssen Cilag, Philippines
  • Janssen Pharmaceutica, Belgium
  • Janssen-Cilag Zug SG DC (RDC)
  • Johnson and Johnson ( Hongkong ) Limited
  • Johnson and Johnson (Philippines) Inc.
  • Johnson and Johnson (China) Investment Limited
  • Johnson and Johnson China Limited
  • Johnson and Johnson Consumer Products Company, USA
  • Johnson and Johnson Consumer Products WW, USA
  • Johnson and Johnson Consumer Services Eame Limited
  • Johnson and Johnson European Logistic Centre, Belgium
  • Johnson and Johnson GFS China, Suzhou
  • Johnson and Johnson Gmbh Germany
  • Johnson and Johnson Health Care Systems Inc., USA
  • Johnson and Johnson Indonesia
  • Johnson and Johnson International, USA
  • Johnson and Johnson International Singapore, Philippines
  • Johnson and Johnson K.K. Japan
  • Johnson and Johnson Korea Limited, Korea
  • Johnson and Johnson Medical ( Shanghai ) Limited, China
  • Johnson and Johnson Medical AG Rechnung
  • Johnson and Johnson Medical Hongkong
  • Johnson and Johnson Medical Indonesia
  • Johnson and Johnson Medical Japan
  • Johnson and Johnson Medical Korea
  • Johnson and Johnson Medical Limited, UK
  • Johnson and Johnson Medical Malaysia
  • Johnson and Johnson Medical Middle East, Dubai
  • Johnson and Johnson Medical N.V/S.A, Belgium
  • Johnson and Johnson Medical Philippines
  • Johnson and Johnson Medical Pty. Limited, Australia
  • Johnson and Johnson Medical Russia
  • Johnson and Johnson Medical S.A. Inc., Vietnam
  • Johnson and Johnson Medical Taiwan
  • Johnson and Johnson Medical Thailand
  • Johnson and Johnson Pacific Pty. Limited, Australia
  • Johnson and Johnson Pakistan (Private) Limited
  • Johnson and Johnson Professional Product, Brazil
  • Johnson and Johnson Professsional Canada
  • Johnson and Johnson Professsional Russia
  • Johnson and Johnson Pte. Limited, Singapore (Johnson and Johnson APSC Singapore)
  • Johnson and Johnson Sales and Logistic Centre
  • Johnson and Johnson SDN BHD, Malaysia
  • Johnson and Johnson Services Inc., USA
  • Johnson and Johnson Srilanka
  • Johnson and Johnson Thailand Limited
  • Johnson and Johnson UK Limited
  • Johnson and Johnson Vision Care Inc., USA
  • Johnson and Johnson Vision Care, China
  • Johnson and Johnson Vision Care, Hong Kong
  • Johnson and Johnson Vision Care, Ireland
  • Johnson and Johnson Vision Care, Malaysia
  • Johnson and Johnson Vision Care, Thailand
  • Lifescan Inc., USA
  • Lifescan Puerto Rico
  • Lifescan Uspaec/Mechanicsburg
  • Mcneil Nutritional USA
  • Mcneil PPC, USA
  • Mcneil USA
  • Medos S.A., Switzerland
  • Mentor Worldwide LLC
  • Neutrogena Corporation, USA
  • Obtech Medical, Switzerland
  • Ortho Clinical Diagnostics Inc., USA
  • Ortho Clinical Diagnostics, Australia
  • Ortho Clinical Diagnostics, France
  • Pharmaceutical Research and Development, USA
  • Tibotec Virco BVBA
  • Xian Janssen Pharmaceutical Limited, China

 

  • NR Jet Enterprises Limited

CIN No.:- U24239MH1981PLC025232

 

 

Enterprises having significant influence :

Depuy Medical Private Limited

CIN No.:- U51900MH1996PTC104318

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2011

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.100/- each

Rs. 150.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1440000

Equity Shares

Rs.100/- each

Rs. 144.000 Millions

 

 

 

 

 

NOTE

 

Of the above, 1,416,000 equity shares are allotted as fully paid bonus shares by capitalization of General Reserve (Johnson and Johnson, U.S.A., the holding company holds 1,080,000 Equity shares of Rs.100/- each)

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

(12 Months)

31.03.2009

(15 Months)

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

144.000

144.000

144.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

8054.593

6287.787

4878.630

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

8198.593

6431.787

5022.630

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

716.667

1433.333

TOTAL BORROWING

0.000

716.667

1433.333

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

8198.593

7148.454

  6455.963

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

4512.222

4337.817

3797.395

Capital work-in-progress

567.471

195.960

650.963

 

 

 

 

INVESTMENT

0.051

0.051

0.051

DEFERREX TAX ASSETS

242.480

169.901

172.867

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

3994.004
2405.440
2061.361

 

Sundry Debtors

2515.076
1840.901
1303.908

 

Cash & Bank Balances

483.699
480.945
1269.510

 

Other Current Assets

0.000
0.000
0.973

 

Loans & Advances

4331.300
3705.844
3218.489

Total Current Assets

11324.079

8433.130

7854.241

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

6777.740
4291.410
4742.280

 

Other Current Liabilities

349.813
373.347

271.206

 

Provisions

1320.157
1323.648
1006.068

Total Current Liabilities

8447.710

5988.405

6019.554

Net Current Assets

2876.369
2444.725
1834.687

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

8198.593

7148.454

6455.963

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

(12 Months)

31.03.2009

(15 Months)

 

SALES

 

 

 

 

 

Income

27117.976

23982.820

24972.596

 

 

Other Income

2551.882

2113.185

2291.994

 

 

TOTAL                                     (A)

29669.858

26096.005

27264.590

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption Materials Change Inventories

11577.156

9835.622

10827.051

 

 

Manufacturing Service Costs

3383.094

2833.070

0.000

 

 

Employee Related Expenses 

3812.183

3300.265

0.000

 

 

Administrative, Selling & Other Expenses 

8097.188

7030.598

12204.603

 

 

Exceptional Item – Demand raised by NPPA 

0.000

0.000

125.913

 

 

TOTAL                                     (B)

26869.621

22999.555

23157.567

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

2800.237

3096.450

4107.023

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

39.903

111.589

228.488

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

2760.334

2984.861

3878.535

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

762.648

710.867

694.489

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

1997.686

2273.994

3184.046

 

 

 

 

 

Less

TAX                                                                  (H)

230.880

534.976

1077.463

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

1766.806

1739.018

2106.583

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

4813.397

3542.135

2235.866

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Interim Dividend

0.000

0.000

504.000

 

 

Proposed Dividend

0.000

252.000

0.000

 

 

Tax on Interim Dividend

0.000

0.000

85.655

 

 

Tax on Proposed Dividend

0.000

41.854

0.000

 

 

General Reserve

0.000

173.902

210.659

 

BALANCE CARRIED TO THE B/S

6580.203

4813.397

3542.135

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

1570.359

1265.314

1224.882

 

 

Rebate on Imports

23.204

18.155

20.228

 

 

Other Earnings

1886.290

1904.484

1890.038

 

 

Sales of Business

255.083

0.000

0.000

 

TOTAL EARNINGS

3734.936

3187.953

3135.148

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

6817.835

5729.353

6062.016

 

 

Stores & Spares

20.196

9.998

9.131

 

 

Capital Goods

269.847

270.405

213.579

 

TOTAL IMPORTS

7107.878

6009.756

6284.726

 

 

 

 

 

 

Earnings Per Share (Rs.)

1226.95

1207.65

1462.90

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

(12 Months)

31.03.2009

(15 Months)

PAT / Total Income

(%)

5.95

6.66

7.73

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

7.37

9.48

12.75

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.42

17.57

27.33

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.24

0.35

0.63

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.03

1.04

1.48

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.34

1.41

1.30

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

SUNDRY CREDITORS DETAILS

(Rs. In Millions)

Particulars

 

31.03.2011

31.03.2010

31.03.2009

Sundry Creditors

 

 

 

Creditors due small micro enterprises

57.503

10.456

0.000

Creditors due others

6720.237

4280.954

4742.280

TOTAL

6777.740

4291.410

4742.280

 

 

TURNOVER

 

Total sales turnover during the year amounted to Rs.27117.976 Millions as compared to the turnover of Rs.23.982.820 Millions for the previous period.

 

 

PROFITS

 

The profit for the year after tax amounted to Rs.1766.806 Millions as compared to the profit of Rs.1739.018 Millions for the previous period.

 

 

FIXED ASSETS

 

  • Freehold Land
  • Leasehold Land
  • Land Improvement
  • Buildings
  • Building Improvement
  • Machinery and Equipments
  • Computer/ IM Equipments
  • Software
  • Vehicles
  • Office Furniture and Equipments
  • Patents and Trade Marks

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 51.61

UK Pound

1

Rs. 83.57

Euro

1

Rs. 67.17

 

 

INFORMATION DETAILS

 

Information Gathered by :

PJA

 

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

67

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.